| Invitation |
 |
| On behalf of DETERMINED, an expert DMD community, you are invited to attend the inaugural DETERMINED Peer-to-Peer virtual meeting–an interactive meeting, focused on best practices in the treatment of Duchenne muscular dystrophy (DMD), sponsored by PTC Therapeutics. Registration is now open, and we hope that you will be able to join. |
| The objective of the DETERMINED Peer-to-Peer program is to provide a forum to discuss best practices and expert clinical insights with the ultimate aim of improving care for patients with DMD. |
| The meeting, which will make use of an online platform allowing participants to join from the comfort of their own home or office, will be an interactive virtual discussion led by a panel of experts in the field. |
|
| Meeting Details |
|
| Date |
Thursday, January 16, 2020 |
|
| Time |
8:00pm to 9:00pm Eastern Time |
|
|
|
|
|
| Expert Speakers |
 |
| Dr. Diana Castro, MD |
UT Southwestern
Medical Center, Dallas, TX |
|
|
 |
| Ms. Regina Laine |
Boston Children’s Hospital,
Boston, MA |
|
|
 |
| Dr. Migvis Monduy, MD |
| Nicklaus Children’s Hospital, Miami, FL |
|
|
|
| The meeting will involve case-based discussion of challenges typically encountered in the clinic such as: |
| • Patients who are approaching loss of ambulation |
| • Patients who experience side effects associated with corticosteroid treatment |
| To accept this invitation, please confirm your attendance by registering by Friday, January 10, 2020. |
|
| If you have any questions about the meeting or registration process, please contact LighthousePTCTeam@weareteamlighthouse.com. |
|
| Click here to unsubscribe from all communications from PTC Therapeutics, Inc. |
Trademarks, registered or otherwise, are the property of their respective
owners. © 2019 PTC Therapeutics, Inc. All Rights Reserved. US-DMD-0201 |
|
|
 |
|
|
|